Analysts think SLS stock price could increase by 350%
Aug 11, 2025, 11:26 AM
1.89%
What does SLS do
SELLAS Life Sciences Group, a clinical stage biopharmaceutical company based in New York, develops immunotherapeutics for cancer, including galinpepimut-S and SLS009. The company went public in 2008 and employs 16 staff.
4 analysts think SLS stock price will increase by 350.47%. The current median analyst target is $7.14 compared to a current stock price of $1.58. The lowest analysts target is $6.06 and the highest analyst target is $7.88.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.